The World Health Organization (WHO) officially declared China a malaria-free country. After registering zero indigenous malaria cases for over three consecutive years, China is now the 40th country or territory to receive the certification, following El Salvador in 2021, Argentina and Algeria in 2019, Paraguay and Uzbekistan in 2018, and Sri Lanka in 2016.

Specialists from the University of Cape Town, Duke-NUS Medical School, Polo di Genomica, Genetica e Biologia and National Health Research Institutes (Taiwan) will gather on July 8 to answer the question - Can gene drive eliminate vector-borne diseases?

Join us for this third session of the Gene Drive Webinar Series. Register here!

The Pan-African Mosquito Control Association (PAMCA) and its Women in Vector Control (WIVC) programme are now receiving applications for the new award themed Recognition of Excellence of Women in Vector Control 2021. Early-, mid- and expert career women who are actively engaged in vector-borne diseases control initiatives in Africa are welcome to apply by July 10.

The awards will be conferred during the Virtual PAMCA Annual Conference & Exhibition on September 20-22.

If you could not join the second panel of the Gene Drive Webinar Series, you can still watch the discussion here!

In this second session, experts from Island Conservation, CSIRO, Manaaki Whenua Landcare Research and the Biological Heritage National Science Challenge evaluated the impact of invasive alien species (IAS) on biodiversity, the limitations of current IAS management tools and the potential of gene drive approaches to address these challenges.

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) of the National Institutes of Health (NIH) will hold a virtual meeting on June 25 to present and deliberate on their report about gene drive application for disease control. The report aims to assess whether existing biosafety guidance is adequate for contained laboratory research utilizing gene drive technology and to outline conditions, if any, under which NIH could consider supporting field release of gene drive modified organisms.